Financial Statements

Profarma Distribuidora de Produtos ... (PFRM3.SA)

$3.68

+0.13 (+3.66%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) --302-286-246-
Net Income 785212-10-113
Stock Dividends -78250-29-30-133
Dividend Paid -----
Retained Earnings ---302-286-246

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 393311129136-
Annual Depreciation 1401272098188
Capital Expenditure -14-45-27-16-52
Net PPE 519393311129136

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -474474440440
New Purchases -51-55-5-3-4
Intangible and Goodwill 474474440440440

Profarma Distribuidora de Produtos Farmacêuticos S.A. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Profarma Distribuidora de Produtos Farmacêuticos S.A. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.